SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    DeMay RM. Fine needle aspiration biopsy. In: DemayRM, editor. The art and science of cytopathology, vol 2. Chicago: ASCP Press, 1996: 464492.
  • 2
    Ljung BM, Drejet A, Chiampi N, et al. Diagnostic accuracy of fine-needle aspiration biopsy is determined by physician training in sampling technique. Cancer (Cancer) Cytopathol. 2001; 93: 263268.
  • 3
    Orell SR, Sterrett GF, Whitaker D. 1ntroduction. 1n: OrellSR, SterrettGF, WhitakerD, editors. Fine Needle Aspiration Cytology. 4th ed. Philadelphia: Elsevier; 2005: 1; 0
  • 4
    Geisinger KR, Stanley MW, Raab SS, Silverman JF, Abati A. Fine-needle aspiration: equipment, basic and clinical techniques, and results reporting. In: GeisingerKR, StanleyMW, RaabSS, SilvermanJF, AbatiA, editors. Modern Cytopathology. Philadelphia: Churchill Livingstone; 2004: 2223.
  • 5
    Trott PA. Efficacy of breast needle aspiration cytodiagnosis. In: TrottPA, editor. Breast Cytopathology: A Diagnostic Atlas. London: Chapman & Hall; 1996: 122123.
  • 6
    Lau SK, McKee GT, Weir MM, Tambouret RH, Eichhorn JH, Pitman MB. The negative predictive value of breast fine-needle aspiration biopsy: the Massachusetts General Hospital experience. Breast J. 2004; 10: 487491.
  • 7
    [Anonymous.] The uniform approach to breast fine-needle aspiration biopsy. N1H Consensus Development Conference. Diagn Cytopathol. 1997;16: 295311.
  • 8
    Pitman MB. Fine needle aspiration biopsy: point of care testing in anatomic pathology. Point Care J Near-Patient Testing Technol. 2002; 1: 7177.
  • 9
    Accreditation Council for Graduate Medical Education (ACGME). List of ACGME accredited programs and sponsoring institutions. Available at: http://www.acgme.org/adspublic/ Accessed May 19, 2006.
  • 10
    Ballo MS, Sneige N. Can core needle biopsy replace fine needle aspiration cytology in the diagnosis of palpable breast carcinoma? Cancer. 1996; 78: 773777.
  • 11
    Raab SS, Nakhleh RE, Ruby SG. Patient safety in anatomic pathology: measuring discrepancy frequencies and causes. Arch Pathol Lab Med. 2005; 129: 459466.
  • 12
    Galera-Davidson H. Diagnostic problems in thyroid FNAs. Diagn Cytopathol. 1997; 17: 422428.
  • 13
    Orell SR, Sterrett GF, Whitaker D. Thyroid. In: OrellSR, SterrettGF, WhitakerD, editors. Fine Needle Aspiration Cytology. 4th ed. Philadelphia: Elsevier; 2005: 125164.
  • 14
    Mittendorf EA, Tamarkin SW, McHenry CR. The results of ultrasound-guided fine-needle aspiration biopsy for evaluation of nodular thyroid disease. Surgery. 2002; 132: 648653.
  • 15
    Laane E, Tani E, Bjorklund E, Elmberger G, Everaus H, Skoog L, Porwit-MacDonald A. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma. Cytometry. 2005; 64: 3442.
  • 16
    Hehn ST, Grogan TM, Miller TP. Utility of fine-needle aspiration as a diagnostic technique in lymphoma. J Clin Oncol. 2004; 22: 30463052.
  • 17
    van Heerde P, Miliauskas JR. Lymph nodes. In: OrellSR, SterrettGF, WhitakerD, editors. Fine Needle Aspiration Cytology. 4th ed. Philadelphia: Elsevier; 2005: 83124.
  • 18
    Abele JS, Miller TR. Implementation of an outpatient needle aspiration biopsy service and clinic: a perspective. In: SchmidtW, editor. Cytopathology Annual. Baltimore: Williams & Wilkins; 1993: 4371.
  • 19
    Lioe TF, Elliott H, Allen DC, Spence RA. The role of fine needle aspiration cytology (FNAC) in the investigation of superficial lymphadenopathy; uses and limitations of the technique. Cytopathology. 2004; 10: 291297.
  • 20
    Nasuti JF, Yu G, Boudousquie A, Gupta P. Diagnostic value of lymph node fine needle aspiration cytology: an institutional experience of 387 cases observed over a 5-year period. Cytopathology. 2000; 11: 1831.
  • 21
    Reyes C5, Thompson KS, Jensen JD, Choudhury AM. Metastasis of unknown origin: the role of fine-needle aspiration cytology. Diagn Cytopathol. 1998; 18: 319322.